• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Other Campus Research
    • ECU Open Access Publishing Support
    • 2018-2019 Open Access Publishing Fund
    • View Item
    •   ScholarShip Home
    • Other Campus Research
    • ECU Open Access Publishing Support
    • 2018-2019 Open Access Publishing Fund
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    N6-methyladenosine contributes to cellular phenotype in a genetically-defined model of breast cancer progression

    Thumbnail
    View/ Open
    Main Article (1.649Mb)

    Show full item record
    Author
    Fry, Nate J.; Law, B. A.; Ilkayeva, O. R.; Holley, C. L.; Mansfield, Kyle D.; Carraway, Kristen R.
    Abstract
    The mRNA modification N6-methyladenosine (m6A) is involved in many post-transcriptional regulatory processes including mRNA stability and translational efficiency. However, it is also imperative to correlate these processes with phenotypic outputs during cancer progression. Here we report that m6A levels are significantly decreased in genetically-defined immortalized and oncogenically-transformed human mammary epithelial cells (HMECs), as compared with their primary cell predecessor. Furthermore, the m6A methyltransferase (METTL3) is decreased and the demethylase (ALKBH5) is increased in the immortalized and transformed cell lines, providing a possible mechanism for this basal change in m6A levels. Although the immortalized and transformed cells showed lower m6A levels than their primary parental cell line, overexpression of METTL3 and METTL14, or ALKBH5 knockdown to increase m6A levels in transformed cells increased proliferation and migration. Remarkably, these treatments had little effect on the immortalized cells. Together, these results suggest that m6A modification may be downregulated in immortalized cells as a brake against malignant progression. Finally, we found that m6A levels in the immortalized and transformed cells increased in response to hypoxia without corresponding changes in METTL3, METTL14 or ALKBH5 expression, suggesting a novel pathway for regulation of m6A levels under stress.
    URI
    http://hdl.handle.net/10342/7356
    Subject
     N6-methyladenosine; RNA modification; breast cancer; hypoxia; transformation 
    Date
    2018-07-27
    Citation:
    APA:
    Fry, Nate J., & Law, B. A., & Ilkayeva, O. R., & Holley, C. L., & Mansfield, Kyle D., & Carraway, Kristen R.. (July 2018). N6-methyladenosine contributes to cellular phenotype in a genetically-defined model of breast cancer progression. , (), - methyladenosine contributes to cellular phenotype in a genetically-defined model of breast cancer progression. Oncotarget, 9(58): 31231-31243. doi: 10.18632/oncotarget.25782.. Retrieved from http://hdl.handle.net/10342/7356

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    Fry, Nate J., and Law, B. A., and Ilkayeva, O. R., and Holley, C. L., and Mansfield, Kyle D., and Carraway, Kristen R.. "N6-methyladenosine contributes to cellular phenotype in a genetically-defined model of breast cancer progression". . . (), July 2018. September 28, 2023. http://hdl.handle.net/10342/7356.
    Chicago:
    Fry, Nate J. and Law, B. A. and Ilkayeva, O. R. and Holley, C. L. and Mansfield, Kyle D. and Carraway, Kristen R., "N6-methyladenosine contributes to cellular phenotype in a genetically-defined model of breast cancer progression," , no. (July 2018), http://hdl.handle.net/10342/7356 (accessed September 28, 2023).
    AMA:
    Fry, Nate J., Law, B. A., Ilkayeva, O. R., Holley, C. L., Mansfield, Kyle D., Carraway, Kristen R.. N6-methyladenosine contributes to cellular phenotype in a genetically-defined model of breast cancer progression. . July 2018; (): . http://hdl.handle.net/10342/7356. Accessed September 28, 2023.
    Collections
    • 2018-2019 Open Access Publishing Fund

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback